default author photo

Miguel A. Molina-Vila

Quirón-Dexeus University Institute - Pangaea Oncology

Spain

  • Quirón-Dexeus University Institute - Pangaea Oncology

SCHOLARLY PAPERS

2

DOWNLOADS

153

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Downloads 117 (608,822)

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Number of pages: 22 Posted: 28 Feb 2025
Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela, Jose Luis Manzano, Pablo Ayala de Miguel, Ana M. Arance, Miguel Angel Berciano Guerrero, Almudena García Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal Jaime, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel A. Molina-Vila, Rafael Rosell, Joan Anton Puig-Butille and Maria Gonzalez-Cao
affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Cartagena, affiliation not provided to SSRN, affiliation not provided to SSRN, Autonomous University of Barcelona - Hospital Germans Trias i Pujol, affiliation not provided to SSRN, Hospital of Barcelona, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario La Paz, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Quirón-Dexeus University Institute - Pangaea Oncology, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona and affiliation not provided to SSRN
Downloads 86 (773,441)

Abstract:

Loading...

Melanoma, BRAF mutation, Liquid Biopsy

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Number of pages: 40 Posted: 06 Jun 2025
Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela, Jose Luis Manzano, Pablo Ayala de Miguel, Ana M. Arance, Miguel Angel Berciano Guerrero, Almudena García Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal Jaime, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel A. Molina-Vila, Rafael Rosell, Joan Anton Puig-Butille and Maria Gonzalez-Cao
affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Cartagena, affiliation not provided to SSRN, affiliation not provided to SSRN, Autonomous University of Barcelona - Hospital Germans Trias i Pujol, affiliation not provided to SSRN, Hospital of Barcelona, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario La Paz, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Quirón-Dexeus University Institute - Pangaea Oncology, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona and affiliation not provided to SSRN
Downloads 31 (1,341,098)

Abstract:

Loading...

Melanoma, BRAF mutation, liquid biopsy

2.

Ros1 Fusions in Resected Stage I-Iii Adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape Project

Number of pages: 38 Posted: 01 May 2024
Ernst-Jan M. Speel, Urania Dafni, Erik Thunissen, Jan Hendrik Rüschoff, Cathal O Brien, Jacek Kowalski, Keith M. Kerr, Lukas Bubendorf, Irene Sansano Valero, Leena Joseph, Mark Kriegsmann, Atilio Navarro, K. Monkhorst, Line Bille Madsen, Javier Hernandez Losa, Wojcicech Biernat, Albrecht Stenzinger, Andrea Rüland, Lisa M. Hillen, Nesa Marti, Miguel A. Molina-Vila, Tereza Dellaporta, Roswitha Kammler, solange peters, Rolf A. Stahel, Stephen P. Finn, Teodora Radonic and Consortium Lungscape
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital Zurich, affiliation not provided to SSRN, Medical University of Gdansk, Aberdeen Royal Infirmary, University of Basel - University Hospital Basel, affiliation not provided to SSRN, The University of Manchester - Manchester University NHS Foundation Trust, Heidelberg University - University Hospital Heidelberg, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, Aarhus University - Aarhus University Hospital, affiliation not provided to SSRN, Medical University of Gdansk, Heidelberg University - Institute of Pathology, affiliation not provided to SSRN, Maastricht University, affiliation not provided to SSRN, Quirón-Dexeus University Institute - Pangaea Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, Centre Hospitalier Universitaire Vaudois (CHUV), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - University Medical Center and affiliation not provided to SSRN
Downloads 36 (1,236,159)

Abstract:

Loading...

ROS1, lung adenocarcinoma, NSCLC, Lungscape